• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒疫苗诱导的逃逸突变株

Vaccine-induced escape mutant of hepatitis B virus.

作者信息

Carman W F, Zanetti A R, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman A J, Thomas H C

机构信息

Department of Medicine, St Mary's Hospital Medical School, London, UK.

出版信息

Lancet. 1990 Aug 11;336(8711):325-9. doi: 10.1016/0140-6736(90)91874-a.

DOI:10.1016/0140-6736(90)91874-a
PMID:1697396
Abstract

In southern Italy, 44 contacts of hepatitis B virus carriers, including infants of carrier mothers, became HBsAg positive despite passive and active immunisation according to standard protocols. In 32 of these vaccinees infection was confirmed by the presence of additional markers of viral replication. In 1 infant, serious disease occurred. The virus from this patient is an escape mutant with a different sequence from that of the isolate from the mother. A point mutation from guanosine to adenosine at nucleotide position 587 resulted in an aminoacid substitution from glycine to arginine in the highly antigenic a determinant of HBsAg. This mutation is stable: it is present in an isolate from the child 5 years later. In some of these patients, including this child, the a determinant, to which a large part of the vaccine-induced immunity is directed, has been partly lost. Binding to HBsAg of a monoclonal antibody, previously mapped to the region of the mutation, was reduced in the child relative to that of the mother.

摘要

在意大利南部,44名乙肝病毒携带者的接触者,包括携带者母亲的婴儿,尽管按照标准方案进行了被动和主动免疫,仍出现乙肝表面抗原(HBsAg)阳性。在这些接种疫苗者中,有32人通过病毒复制的其他标志物证实感染。有1名婴儿发生了严重疾病。该患者的病毒是一种逃逸突变株,其序列与母亲的病毒分离株不同。核苷酸位置587处从鸟苷到腺苷的点突变导致乙肝表面抗原高抗原性a决定簇中的氨基酸从甘氨酸替换为精氨酸。这种突变是稳定的:5年后在该儿童的病毒分离株中仍存在。在包括该儿童在内的一些患者中,疫苗诱导的大部分免疫所针对的a决定簇已部分丧失。与母亲相比,该儿童中先前定位到突变区域的单克隆抗体与乙肝表面抗原的结合减少。

相似文献

1
Vaccine-induced escape mutant of hepatitis B virus.乙型肝炎病毒疫苗诱导的逃逸突变株
Lancet. 1990 Aug 11;336(8711):325-9. doi: 10.1016/0140-6736(90)91874-a.
2
Hepatitis B vaccination.乙肝疫苗接种
Hum Vaccin Immunother. 2015;11(1):53-7. doi: 10.4161/hv.34306. Epub 2014 Nov 1.
3
Independent emergence of a vaccine-induced escape mutant of hepatitis B virus.
J Hepatol. 1991;13 Suppl 4:S105-7. doi: 10.1016/0168-8278(91)90037-c.
4
Hepatitis B virus: the Houdini of hepatology?
Gastroenterology. 1991 Feb;100(2):578-9. doi: 10.1016/0016-5085(91)90242-d.
5
Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.疫苗和乙型肝炎免疫球蛋白诱导的乙型肝炎病毒表面抗原逃逸突变
J Biomed Sci. 2001 May-Jun;8(3):237-47. doi: 10.1007/BF02256597.
6
Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus.乙型肝炎病毒免疫逃逸突变体的乙肝表面抗原中甘氨酸145被精氨酸取代。
Biochem Biophys Res Commun. 1992 May 15;184(3):1152-7. doi: 10.1016/s0006-291x(05)80003-8.
7
A new vaccine escape mutant of hepatitis B virus causes occult infection.一种新型乙肝病毒疫苗逃逸突变体导致隐匿性感染。
Hum Vaccin Immunother. 2015;11(2):407-10. doi: 10.4161/21645515.2014.994461.
8
Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.乙肝表面抗原阳性携带者母亲所生婴儿的乙肝病毒感染免疫预防
J Infect Dis. 1985 Oct;152(4):817-22. doi: 10.1093/infdis/152.4.817.
9
Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants.
J Infect Dis. 1999 Jan;179(1):259-63. doi: 10.1086/314553.
10
Vaccination against hepatitis B virus infection in neonates.新生儿乙型肝炎病毒感染的疫苗接种。
Helv Paediatr Acta. 1984 Aug;39(3):231-6.

引用本文的文献

1
Hepatitis B virus infection after immunization: How serious it is? An updated review.免疫接种后感染乙肝病毒:有多严重?最新综述。
Clin Exp Med. 2025 Apr 10;25(1):113. doi: 10.1007/s10238-025-01645-8.
2
Molecular Mechanisms and Therapeutic Targets of Hepatitis B Virus Pre-S Mutant-Associated Hepatocellular Carcinoma Tumorigenesis.乙型肝炎病毒前S区突变相关肝细胞癌发生的分子机制及治疗靶点
Cancer Control. 2025 Jan-Dec;32:10732748251320492. doi: 10.1177/10732748251320492.
3
A novel method for recombinant mammalian-expressed S-HBsAg virus-like particle production for assembly status analysis and improved anti-HBs serology.
一种用于重组哺乳动物表达的S-HBsAg病毒样颗粒生产以进行组装状态分析和改善抗-HBs血清学的新方法。
Protein Sci. 2025 Jan;34(1):e5251. doi: 10.1002/pro.5251.
4
Comprehensive genome analysis of hepatitis B virus using nanopore sequencing technology in patients with previously resolved infection and spontaneous reactivation without drug exposure.利用纳米孔测序技术对既往感染已愈且无药物暴露情况下发生自发再激活的乙型肝炎病毒患者进行全基因组分析。
Clin J Gastroenterol. 2025 Feb;18(1):145-153. doi: 10.1007/s12328-024-02078-8. Epub 2024 Dec 3.
5
Regulation of Hepatitis B Virus Replication by Modulating Endoplasmic Reticulum Stress (ER-Stress).通过调节内质网应激(ER应激)来调控乙型肝炎病毒复制
Int J Microbiol. 2024 Aug 30;2024:9117453. doi: 10.1155/2024/9117453. eCollection 2024.
6
Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.中、大 envelope 蛋白均可通过抗前 S2 抗体介导乙型肝炎病毒感染性中和:自然发生的前 S2 缺失逃逸。
J Virol. 2024 Aug 20;98(8):e0192923. doi: 10.1128/jvi.01929-23. Epub 2024 Jul 30.
7
Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030.全球乙肝疫苗接种的视角:挑战、成就以及2030年实现消除的道路
Vaccines (Basel). 2024 Mar 9;12(3):288. doi: 10.3390/vaccines12030288.
8
Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies.乙肝表面抗原亚型:它们的临床意义、在诊断、预防中的应用及新的抗病毒策略
Pathogens. 2024 Jan 3;13(1):46. doi: 10.3390/pathogens13010046.
9
Managing HBV and HCV Infection Pre- and Post-liver Transplant.肝移植前后的乙肝病毒和丙肝病毒感染管理
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101287. doi: 10.1016/j.jceh.2023.09.008. Epub 2023 Sep 23.
10
Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.REP 2139 对 CRISPR/Cas9 工程细胞系表达乙型肝炎病毒表面抗原的泛基因组抗病毒作用。
PLoS One. 2023 Nov 1;18(11):e0293167. doi: 10.1371/journal.pone.0293167. eCollection 2023.